propofol has been researched along with Mastocytosis, Systemic in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulbrich, F | 1 |
| Engelstädter, H | 1 |
| Wittau, N | 1 |
| Steinmann, D | 1 |
1 other study available for propofol and Mastocytosis, Systemic
| Article | Year |
|---|---|
Anaesthetic management of emergency caesarean section in a parturient with systemic mastocytosis.
Topics: Abdominal Pain; Adult; Anesthesia, General; Anesthesia, Obstetrical; Anesthetics, Intravenous; Cesar | 2013 |